United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News Haoma Medica completes first-in-human trial of NaQuinate, a promising osteoporosis treatment Haoma Medica, a UK-based biotechnology company, has successfully wrapped up the first-in-human clinical trial of NaQuinate, a novel… bypharmanewsdailyNovember 28, 2020